EVs secreted by breast cancer cells have been reported to stimulate NF-κB activation in macrophages, leading to the secretion of inflammatory cytokines such as IL-6, tumor necrosis factor-alpha (TNFα), granulocyte colony-stimulating factor (GCSF), and CCL2. This evidence concerns the gene NFKB1 and breast carcinoma.